Impact of Vitamin D on Infectious Disease
The American Journal of the Medical Sciences, Volume 349, Issue 3, March 2015, Pages 245-262, https://doi.org/10.1097/MAJ.0000000000000360
lMalcolm D.Kearns BS Jessica A.Alvarez PhD Natan Seidel BS VinTangpricha MD, PhD
Overview Tuberculosis and Vitamin D
Respiratory infections reduced by 63 percent with 4000 IU vitamin D daily - RCT Dec 2012
- Vitamin D and Respiratory Tract Infections – meta-analysis with charts June 2013
- Respiratory infections reduced only 20 percent by Vitamin D (ignored dose size, duration, type, etc) – meta-analysis Jan 2019
- Respiratory Tract Infection visits 2.5 less likely with vitamin D: Pregnancy 2000 IU, Infant 800 IU – RCT Oct 2014
- 100 % of Acute Respiratory Failure patients had low vitamin D - April 2012
- All items in Breathing and Vitamin D
455 items - Acute lower respiratory infection 5X more frequent with low vitamin D intake – June 2012
- Hypothesis: Respiratory problems will decrease with increased vitamin D – Jan 2012
- Respiratory Virus risk reduced 35 percent by Vitamin D (14,000 IU weekly) – RCT Oct 2018
- Respiratory diseases helped by vitamin D if initially have low level – RCT review Jan 2015
- Common cold incidence reduced by two thirds (500 IU for IBD with low vitamin D) – RCT Jan 2019
- Inflammatory diseases: review of vitamin D, with many tables – May 2014 which has the following summary table
Download the PDF from VitaminDWiki
RTI - Positive Studies
TB - Positive Studies
Background
Observational studies have linked vitamin D status and infectious disease. This association is supported by the presence of the vitamin D receptor and CYP27B1 in immune cells. This review aims to consolidate data from clinical trials that used vitamin D for the treatment or prevention of infectious disease.Methods
The authors searched the term "(vitamin D OR ergocalciferol OR cholecalciferol OR vitamin D2 OR vitamin D3 OR calcitriol) AND (infection OR tuberculosis OR sepsis OR pneumonia)" with limits preset to manuscripts published in English and with human subjects. They identified controlled trials that measured infectious outcomes (eg, incidence and severity of disease, time to disease resolution or recurrence, measures of clinical improvement, mortality). Studies that used analog, topical or micronutrient formulations of vitamin D, assessed only vitamin D status or lacked a comparison group were excluded. The references from eligible manuscripts and from 2 recent reviews were scanned for additional manuscripts.Results
One thousand two hundred eighty-four manuscripts were identified with our search terms, with 60 papers still eligible after review of the title and abstract. Full review of these papers, their references and 2 related reviews yielded 38 manuscripts.Conclusions
Although some prospective studies show positive results regarding vitamin D on infectious disease, several robust studies are negative. Factors such as high variability between studies, the difference in individual responsiveness to vitamin D and study designs that do not primarily investigate infectious outcomes may mask the effects of vitamin D on infections.Vitamin D does not reduce Infectious Disease when not enough is given – March 2015Printer Friendly Follow this page for updates8979 visitors, last modified 12 Feb, 2020, This page is in the following categories (# of items in each category)Attached files
ID Name Uploaded Size Downloads 13484 TB Positive studies.jpg admin 12 Feb, 2020 195.13 Kb 567 13483 RTI summary.jpg admin 12 Feb, 2020 208.87 Kb 538 13482 Impact of Vitamin D on Infectious Disease.pdf admin 12 Feb, 2020 668.85 Kb 494